Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda

April 6, 2016 1:23 PM | 1 min read | Make a Comment
Loading...
Loading...
Mylan NVMYL
announced in early February it has entered into an agreement to acquire Sweden-based Meda. Following the breakup of
Pfizer Inc.PFE
's proposed merger with
Allergan plcAGN
, investors are focusing in on other active M&A deals within the sector.
Bloomberg reported on Wednesday that Mylan remains "comfortable moving forward" with its proposed $7.2 billion acquisition of Meda. Mylan moved its headquarters from Pittsburgh to the Netherlands last year following its acquisition of Abbott Laboratories' generic drug business in international markets including Europe. Shares of Mylan were trading higher by nearly 5 percent early Wednesday afternoon.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: Newsabbott laboratoriesBloombergmylanTax Inversion
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!